Sample distribution business consolidates with Knipper acquiring MediMedia Health's asset
Knipper claims No. 1 position as national provider of sample distribution for pharma
J. Knipper and Co. (Lakewood, NJ) has been on a steady acquisition trail for the past several years, having acquired Pharmagistics, a sample-management firm, from Publicis Touchpoint Solutions in 2010, and the MySTRO sampling business of inVentiv Health last spring. Now, it has acquired the sampling business of MediMedia Health, a marketing services company, for an undisclosed price, and lays claim to being the No. 1 sample-distribution firm in the US, with warehousing capacity in excess of 600,000 sq. ft.
Company statements point to the evolution going on in sampling: the rise of direct-to-physician (DTP) sampling (which sometimes occurs without the intervention of a sales rep) and direct-to-consumer (DTC) sampling as part of patient assistance programs or other types of prescription fulfillment. The company, which also provides printing and direct mail services, puts an emphasis on closed-loop marketing so that sampling occurs in a context of multichannel interactions with prescribers. “We look forward to transforming the way the industry views ROI and samples management benchmarking,” said Michael LaFerrera, president, in a statement. “Through our integration of the new business, Knipper plans on harnessing the knowledge possessed in its data to provide smarter and more productive tools to its customer base.”
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
